Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/FCF ratio is N/A as of 2026-10-06T21:36:28.235Z.
Calculation as of: 2026-10-06T21:36:28.235Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 4d5e19f74cb926d0196b5f3ffb65db8ff8affa0edec331fa5277d4ca2ec73e8d
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/FCF RATIO
N/A
Decoy Therapeutics Inc.
Market Cap
$824550.00
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$838843.00
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$868077.00
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$946332.00
Price/FCF Ratio
N/A
TTM Avg
13238.57
3Y Avg
13238.57
5Y Avg
13238.57
Market Cap
$667469.00
Price/FCF Ratio
N/A
TTM Avg
837939.80
3Y Avg
5687342.72
5Y Avg
5687342.72
Market Cap
$1.01M
Price/FCF Ratio
N/A
TTM Avg
60791.74
3Y Avg
60791.74
5Y Avg
60791.74
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | $824550.00 | N/A | N/A | N/A | N/A |
| Ridgetech, Inc. (RDGT)vs › | $835994.00 | N/A | 0.22 | 0.19 | 1.45 |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $838843.00 | N/A | N/A | N/A | N/A |
| Bone Biologics Corporation (BBLG)vs › | $868077.00 | N/A | N/A | N/A | N/A |
| GlucoTrack, Inc. (GCTK)vs › | $901902.00 | N/A | N/A | N/A | N/A |
| CDT Equity Inc. (CDT)vs › | $716854.00 | N/A | 0.46 | 0.46 | 0.46 |
| Sunshine Biopharma, Inc. (SBFM)vs › | $946332.00 | N/A | 13238.57 | 13238.57 | 13238.57 |
| China SXT Pharmaceuticals, Inc. (SXTC)vs › | $667469.00 | N/A | 837939.80 | 5687342.72 | 5687342.72 |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.01M | N/A | 60791.74 | 60791.74 | 60791.74 |
| Clearmind Medicine Inc. (CMND)vs › | $1.08M | N/A | N/A | N/A | N/A |
P/FCF Ratio
N/A
FCF Yield
N/A
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
